Increasing Use Of Interferon Gamma Release Assays Among Children ≥2 Years of Age in a Setting With Low Tuberculosis Prevalence. Issue 12 (10th October 2022)

• Record Type: Journal Article
• Authors: Campbell, Jeffrey I.; Tabatneck, Mary; Sun, Mingwei; He, Wei; Musinguzi, Nicholas; Hedt-Gauthier, Bethany; Lamb, Gabriella S.; Goldmann, Don; Sabharwal, Vishakha; Sandora, Thomas J.; Haberer, Jessica E.
• Is Part Of: Pediatric infectious disease journal. Volume 41:Issue 12(2022)
• Page Start: e534
• Page End: e537
• Publication Date: 2022-10-10
• Subjects: interferon gamma release assay -- latent tuberculosis -- pediatric -- tuberculin; Communicable diseases in children -- Periodicals; Infection in children -- Periodicals; 618.929
• DOI: 10.1097/INF.0000000000003685
• Languages: English
• ISSNs: 0891-3668

Abstract

Abstract : US guidelines recommend interferon gamma release assays (IGRAs) for diagnosis of tuberculosis infection in children. In this retrospective cohort study, IGRA use in children 2–17 years of age increased substantially between 2015 and 2021. Testing in inpatient/subspecialty settings (vs. primary care), public (vs. private) insurance, lower age and non-English preferred language were associated with increased odds of receiving an IGRA.